Tainan, Taiwan

Yung-Fa Chen



 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 59(Granted Patents)


Location History:

  • Tainan County, TW (2006 - 2013)
  • Tainan, TW (1993 - 2015)

Company Filing History:


Years Active: 1993-2015

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yung-Fa Chen

Introduction

Yung-Fa Chen, based in Tainan, Taiwan, is a prominent inventor recognized for his significant contributions to the pharmaceutical field. With a portfolio of 14 patents, his innovative spirit has paved the way for advancements in drug development and therapeutics. His work primarily focuses on the synthesis of pharmaceutical intermediates and novel forms of important compounds.

Latest Patents

Among his latest patented inventions are the "Intermediates for the Preparation of Lubiprostone" and "Crystalline and Non-Crystalline Forms of SGLT2 Inhibitors." The first patent presents intermediates crucial for the synthesis of Lubiprostone, a medication for certain gastrointestinal conditions. The second patent introduces amorphous and crystalline forms of SGLT2 inhibitors, highlighting the crystalline forms of canagliflozin, designated as Forms CS1, CS2, CS3, CS4, and CS5. These innovations reflect Chen's expertise in developing vital pharmaceutical compounds that enhance therapeutic efficacy.

Career Highlights

Yung-Fa Chen has made significant strides in his career, particularly during his tenure at Scinopharm Taiwan, Ltd. and Vanderbilt University. His work in these reputable institutions has enabled him to collaborate with other experts in the field and further his research in pharmaceutical sciences. His career is marked by a commitment to improving drug formulations and accessibility for patients.

Collaborations

In his quest for innovation, Chen has collaborated with notable colleagues, including Julian Paul Henschke and Yuanlian Liu. These collaborations have fostered a rich environment for research and development, leading to breakthrough inventions that are pushing the boundaries of pharmaceutical technology.

Conclusion

Yung-Fa Chen stands out as a leading inventor in the pharmaceutical industry. With a strong portfolio of patents and a dedication to advancing drug development, his work has not only contributed to scientific knowledge but has also enhanced therapeutic options for patients worldwide. His innovative mindset continues to drive progress in the field, making a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…